These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 9669419)

  • 1. Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy?
    Weir MR; Dworkin LD
    Am J Kidney Dis; 1998 Jul; 32(1):1-22. PubMed ID: 9669419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Salt Intake on the Pathogenesis and Treatment of Hypertension.
    Rust P; Ekmekcioglu C
    Adv Exp Med Biol; 2017; 956():61-84. PubMed ID: 27757935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effects of antihypertensive drugs.
    Preston RA
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):19S-32S. PubMed ID: 10077416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and hypertension: how low should you go and with which drugs?
    Weir MR
    Am J Hypertens; 2001 May; 14(5 Pt 2):17S-26S. PubMed ID: 11370956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of arterial hypertension in the progression of non-diabetic glomerular diseases.
    Ljutić D; Kes P
    Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v28-30. PubMed ID: 12817064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary salt intake, blood pressure and the kidney in hypertensive patients with non-insulin dependent diabetes mellitus.
    Campese VM; Wurgaft A; Safa M; Bianchi S
    J Nephrol; 1998; 11(6):289-95. PubMed ID: 10048494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern antihypertensive treatment and the progression of renal disease.
    Bauer JH
    J Hypertens Suppl; 1998 Oct; 16(5):S17-24. PubMed ID: 9869000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antihypertensive therapy in chronic kidney disease: what targets and how to reach them].
    Bock A
    Ther Umsch; 2018; 75(6):365-369. PubMed ID: 30880625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does antihypertensive therapy protect the kidney in essential hypertension?
    Rodicio JL
    J Hypertens Suppl; 1996 Sep; 14(2):S69-75; discussion S75-6. PubMed ID: 8934381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertension's 3 Dilemmas and 3 Solutions: Pharmacology of the Kidney in Hypertension.
    Pettinger WA
    J Cardiovasc Pharmacol; 2017 Mar; 69(3):129-139. PubMed ID: 28267687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
    Fodor JG; Whitmore B; Leenen F; Larochelle P
    CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochrane in context: pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh RS
    Evid Based Child Health; 2014 Sep; 9(3):581-3. PubMed ID: 25236306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.